Schwartz JJ et al. |
Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. |
2007 |
Transplantation |
pmid:17893604
|
Yamagami S et al. |
Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506. |
1997 |
Transplantation |
pmid:9233699
|
Ouyang J et al. |
Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections. |
2005 |
Transplantation |
pmid:15912108
|
Neuhaus P et al. |
Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. |
1995 |
Transplantation |
pmid:7530868
|
Tzakis AG et al. |
Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. |
2003 |
Transplantation |
pmid:12717207
|
Villanueva G and Baldwin D |
Rosiglitazone therapy of posttransplant diabetes mellitus. |
2005 |
Transplantation |
pmid:16340782
|
Numakura K et al. |
Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. |
2005 |
Transplantation |
pmid:16340785
|
Ashokkumar C et al. |
Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation. |
2011 |
Transplantation |
pmid:21747326
|
Kim CD et al. |
Metabonomic analysis of serum metabolites in kidney transplant recipients with cyclosporine A- or tacrolimus-based immunosuppression. |
2010 |
Transplantation |
pmid:20842074
|
Shield CF et al. |
Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9422413
|
Takeguchi N et al. |
Inhibition of the multidrug efflux pump in isolated hepatocyte couplets by immunosuppressants FK506 and cyclosporine. |
1993 |
Transplantation |
pmid:7681229
|
Demetris AJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. |
1992 |
Transplantation |
pmid:1374944
|
Bundick RV et al. |
FK506 as an agonist to induce inhibition of interleukin 2 production. |
1992 |
Transplantation |
pmid:1374947
|
Casey MJ et al. |
Prolonged immunosuppression preserves nonsensitization status after kidney transplant failure. |
2014 |
Transplantation |
pmid:24717218
|
Kasahara M et al. |
Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor. |
2001 |
Transplantation |
pmid:11211185
|
Ovuworie CA et al. |
Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. |
2001 |
Transplantation |
pmid:11685108
|
Mourad G et al. |
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. |
2001 |
Transplantation |
pmid:11579299
|
Manitpisitkul W et al. |
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. |
2009 |
Transplantation |
pmid:19584685
|
Dominguez J et al. |
Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience. |
2000 |
Transplantation |
pmid:11063349
|
Jiang H et al. |
Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production. |
2002 |
Transplantation |
pmid:12085006
|
Nogueira JM et al. |
A comparison of recipient renal outcomes with laparoscopic versus open live donor nephrectomy. |
1999 |
Transplantation |
pmid:10096529
|
Shapiro R et al. |
Posttransplant diabetes in pediatric recipients on tacrolimus. |
1999 |
Transplantation |
pmid:10096540
|
Wasik M et al. |
Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro. |
1991 |
Transplantation |
pmid:1702910
|
Merkle M et al. |
The effect of sevelamer on tacrolimus target levels. |
2005 |
Transplantation |
pmid:16177649
|
Cooper MH et al. |
Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors. |
1994 |
Transplantation |
pmid:7509089
|
Lo A et al. |
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. |
2004 |
Transplantation |
pmid:15114090
|
Shoker A et al. |
Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. |
2000 |
Transplantation |
pmid:10949194
|
Egawa H et al. |
Isolated alkaline phosphatemia following pediatric liver transplantation in the FK506 ERA. |
1995 |
Transplantation |
pmid:7533958
|
Wallia A et al. |
Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. |
2010 |
Transplantation |
pmid:20098286
|
Yoshimura N et al. |
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity. |
1989 |
Transplantation |
pmid:2465592
|
Yoshimura N et al. |
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2. |
1989 |
Transplantation |
pmid:2465593
|
Jacobson PA et al. |
Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium. |
2012 |
Transplantation |
pmid:22334041
|
Schneeberger S et al. |
Cytomegalovirus-related complications in human hand transplantation. |
2005 |
Transplantation |
pmid:16123716
|
Qi S et al. |
Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey. |
2000 |
Transplantation |
pmid:10798741
|
McDiarmid SV et al. |
Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients. |
1993 |
Transplantation |
pmid:7685933
|
Borger P et al. |
Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells. |
2000 |
Transplantation |
pmid:10798763
|
Ceulemans LJ et al. |
Nonsteroidal anti-inflammatory drug-induced intestinal graft loss 12 years after transplantation. |
2015 |
Transplantation |
pmid:25695790
|
Ochiai T et al. |
Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs. |
1989 |
Transplantation |
pmid:2474209
|
Kasahara M et al. |
Role of HLA compatibility in pediatric living-related liver transplantation. |
2002 |
Transplantation |
pmid:12438966
|
Hudnall SD |
Cardiac hypertrophy postliver transplantation: a role for FK506 and cyclosporine A? |
2002 |
Transplantation |
pmid:12369583
|
Fukushima D et al. |
Epstein-Barr virus--associated posttransplantation lymphoproliferative disorder with tacrolimus metabolism deterioration in infants after living-donor liver transplantation. |
2015 |
Transplantation |
pmid:24846306
|
Metcalfe S and Milner J |
Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A. |
1991 |
Transplantation |
pmid:1710844
|
Chan L et al. |
Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness. |
2008 |
Transplantation |
pmid:18360262
|
de Jonge H et al. |
Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation. |
2010 |
Transplantation |
pmid:20592652
|
Puig I Marà JM et al. |
Reflex sympathetic dystrophy syndrome of the lower limbs in a renal transplant patient treated with tacrolimus. |
2000 |
Transplantation |
pmid:10919604
|
Erickson LM et al. |
Microarray-based gene expression profiles of allograft rejection and immunosuppression in the rat heart transplantation model. |
2003 |
Transplantation |
pmid:12923448
|
Maluccio M et al. |
Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. |
2003 |
Transplantation |
pmid:12923450
|
Ryu S and Yasunami Y |
The necessity of differential immunosuppression for prevention of immune rejection by FK506 in rat islet allografts transplanted into the liver or beneath the kidney capsule. |
1991 |
Transplantation |
pmid:1718064
|
Mendez R et al. |
A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. |
2005 |
Transplantation |
pmid:16082323
|
Wang HD et al. |
Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation. |
2018 |
Transplantation |
pmid:29298238
|